The Impact of Rapid On-site Evaluation on Diagnostic Performance of Computed Tomography-Guided Core Needle Biopsy in Lung Cancer.
Journal
Journal of computer assisted tomography
ISSN: 1532-3145
Titre abrégé: J Comput Assist Tomogr
Pays: United States
ID NLM: 7703942
Informations de publication
Date de publication:
22 Mar 2024
22 Mar 2024
Historique:
medline:
23
3
2024
pubmed:
23
3
2024
entrez:
22
3
2024
Statut:
aheadofprint
Résumé
Rapid on-site-evaluation (ROSE) is a technique aimed at improving the diagnostic performance of computed tomography (CT)-guided core needle biopsy (CNB) in lung cancer. The aim of this retrospective study was to investigate the impact of ROSE on the rate of nondiagnostic specimens and on accuracy computed on diagnostic specimens. During a 3-year period, 417 CT-guided CNBs were performed at our center. The biopsies were retrospectively classified into 2 groups: 141 procedures were assisted by ROSE and 276 were not. All of them were reviewed for clinical, procedural, and pathological data. Pathology results were classified as diagnostic (positive or negative for malignancy) or nondiagnostic. The results were compared with the final diagnosis after surgery or clinical follow-up. Nondiagnostic rate, sensitivity/specificity/negative predictive value/positive predictive value for the ROSE and non-ROSE groups were calculated. Finally, procedural complications and the adequacy of the specimens for the molecular analysis were recorded. The study evaluated 417 CNBs (mean patients' age 71 years, 278 men). Nondiagnostic rates with and without ROSE were 4% (6/142) and 11% (29/276), respectively (P = 0.028). Sensitivity/specificity/negative predictive value/positive predictive value with and without ROSE did not show statistically significant differences, and no difference in major/minor complication rates was observed between the 2 groups. The adequacy of specimen for subsequent molecular analysis was 100% with (42/42) and 82% without ROSE (51/62). Rapid on-site-evaluation reduced the rate of nondiagnostic specimens by 50% with no change in complication rates or accuracy and increased by 20% the chances of a successful subsequent molecular analysis.
Identifiants
pubmed: 38518357
doi: 10.1097/RCT.0000000000001606
pii: 00004728-990000000-00297
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Manhire A, Charig M, Clelland C, et al; BTS. Guidelines for radiologically guided lung biopsy. Thorax. 2003;58:920–936.
American College of Radiology. ACR–SIR–SPR practice parameter on informed consent for image-guided procedures. Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/PNB.pdf. Accessed February 15, 2024.
Laurent F, Montaudon M, Latrabe V, et al. Percutaneous biopsy in lung cancer. Eur J Radiol. 2003;45:60–68.
Zhang HF, Zeng XT, Xing F, et al. The diagnostic accuracy of CT-guided percutaneous core needle biopsy and fine needle aspiration in pulmonary lesions: a meta-analysis. Clin Radiol. 2016;71:e1–e10.
Tongbai T, McDermott S, Kiranantawat N, et al. Non-diagnostic CT-guided percutaneous needle biopsy of the lung: predictive factors and final diagnoses. Korean J Radiol. 2019;20:1515–1526.
Borelli C, Vergara D, Simeone A, et al. CT-guided transthoracic biopsy of pulmonary lesions: diagnostic versus nondiagnostic results. Diagnostics (Basel). 2022;12:359.
Rui Y, Han M, Zhou W, et al. Non-malignant pathological results on transthoracic CT guided core-needle biopsy: when is benign really benign? Clin Radiol. 2018;73:757.e1–757.e7.
Fontaine-Delaruelle C, Souquet PJ, Gamondes D, et al. Negative predictive value of transthoracic core-needle biopsy: a multicenter study. Chest. 2015;148:472–480.
Chen X, Wan B, Xu Y, et al. Efficacy of rapid on-site evaluation for diagnosing pulmonary lesions and mediastinal lymph nodes: a systematic review and meta-analysis. Transl Lung Cancer Res. 2019;8:1029–1044.
Fassina A, Corradin M, Zardo D, et al. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–312.
Yiminniyaze R, Zhang X, Zhang Y, et al. Diagnostic efficiency and safety of rapid on-site evaluation combined with CT-guided transthoracic core needle biopsy in suspected lung cancer patients. Cytopathology. 2022;33:439–444.
Liu W, Xu C, Li L, et al. The value of computed tomography-guided percutaneous lung biopsy combined with rapid on-site evaluation in diagnosis of peripheral pulmonary nodules. Technol Cancer Res Treat. 2022;21:15330338221118718.
Ferguson PE, Sales CM, Hodges DC, et al. Effects of a multidisciplinary approach to improve volume of diagnostic material in CT-guided lung biopsies. PloS One. 2015;10:e0140998.
Wu D, Liu YY, Wang T, et al. Computed tomography-guided lung biopsy with rapid on-site evaluation for diagnosis of lung lesions: a meta-analysis. J Cardiothorac Surg. 2023;18:122.
Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202.
Huang MD, Weng HH, Hsu SL, et al. Accuracy and complications of CT-guided pulmonary core biopsy in small nodules: a single-center experience. Cancer Imaging. 2019;19:51.
Sheth RA, Baerlocher MO, Connolly BL, et al. Society of Interventional Radiology quality improvement standards on percutaneous needle biopsy in adult and pediatric patients. J Vasc Interv Radiol. 2020;31:1840–1848.
Kim JI, Park CM, Kim H, et al. Non-specific benign pathological results on transthoracic core-needle biopsy: how to differentiate false-negatives? Eur Radiol. 2017;27:3888–3895.
Rigiroli F, Hamam O, Kavandi H, et al. Routine radiology-pathology concordance evaluation of CT-guided percutaneous lung biopsies increases the number of cancers identified. Eur Radiol. 2023. doi:10.1007/s00330-023-10353-4.
doi: 10.1007/s00330-023-10353-4
Rekhtman N, Kazi S, Yao J, et al. Depletion of core needle biopsy cellularity and DNA content as a result of vigorous touch preparations. Arch Pathol Lab Med. 2015;139:907–912.
Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol. 2002;27:1–4.